GQD28 targets unique AD binding sites near protofibril interfaces, including disaggregation sites with EGCG. GQD7 binds broadly, predominantly interacting with PHF6. Potential for detecting, preventing, and disassembling tau aggregates in AD. Here, MAPT is linked to Alzheimer disease.